GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Almado Inc (TSE:4932) » Definitions » COGS-to-Revenue

Almado (TSE:4932) COGS-to-Revenue : 0.32 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Almado COGS-to-Revenue?

Almado's Cost of Goods Sold for the three months ended in Dec. 2023 was 円638 Mil. Its Revenue for the three months ended in Dec. 2023 was 円2,026 Mil.

Almado's COGS to Revenue for the three months ended in Dec. 2023 was 0.32.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Almado's Gross Margin % for the three months ended in Dec. 2023 was 68.49%.


Almado COGS-to-Revenue Historical Data

The historical data trend for Almado's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almado COGS-to-Revenue Chart

Almado Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
COGS-to-Revenue
Get a 7-Day Free Trial 0.43 0.38 0.38 0.38 0.33

Almado Quarterly Data
Mar18 Mar19 Dec19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.36 0.35 0.30 0.32

Almado COGS-to-Revenue Calculation

Almado's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2178.717 / 6528.885
=0.33

Almado's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=638.32 / 2025.823
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Almado  (TSE:4932) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Almado's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 638.32 / 2025.823
=68.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Almado COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Almado's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Almado (TSE:4932) Business Description

Traded in Other Exchanges
N/A
Address
3-6-18 Kyobashi, Chuo-ku, 8th Floor, Tokyo Building Kyobashi Building, Tokyo, JPN, 104-0031
Almado Inc is engaged in planning, development and sales of cosmetics and supplements. The company develops its product from egg shell membrane that is a thin film inside the egg shell. Its product brands include TO-II, Ode, CELLULA, Type III, AMF, Almado La Dina, and other basic cosmetics, makeup cosmetics, supplements, and quasi-drugs.

Almado (TSE:4932) Headlines

No Headlines